<DOC>
	<DOCNO>NCT01073514</DOCNO>
	<brief_summary>To investigate bile culture susceptibility test patient malignant biliary obstruction ( MBO ) relation bile , portal vein vein culture biliary infection . Also get information bile metabonomics find potential tumor marker .Culture organism recognize `` gold standard '' diagnosis infection . Our research may one first research culture susceptibility test patient MBO . The result trial research benefit experiential therapy MBO biliary infection diagnosis MBO .</brief_summary>
	<brief_title>Clinical Trial Bile Etiology , Proteomics Metabonomics Malignant Biliary Obstruction</brief_title>
	<detailed_description>We obtain bile sample culture susceptibility , proteomics metabonomics test PTBD . Also get blood urine sample .</detailed_description>
	<criteria>Those MBO receive Percutaneous Transhepatic Biliary Drainage ( PTBD ) Those MBO receive Percutaneous Transhepatic Biliary Drainage ( PTBD )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Malignant biliary obstruction ( MBO )</keyword>
</DOC>